A detailed history of Barrett & Company, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Barrett & Company, Inc. holds 40 shares of BDX stock, worth $9,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$9,107
Previous $9.35 Million 3.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$232.24 - $267.23 $6,734 - $7,749
-29 Reduced 42.03%
40 $9.75 Million
Q3 2023

Oct 23, 2023

BUY
$254.9 - $283.59 $7,392 - $8,224
29 Added 72.5%
69 $17.8 Million
Q1 2023

May 11, 2023

BUY
$229.71 - $259.35 $9,188 - $10,374
40 New
40 $9.9 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Barrett & Company, Inc. Portfolio

Follow Barrett & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barrett & Company, Inc. with notifications on news.